Microbot Medical Inc. (MBOT)
Company Description
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.
It has 42 issued/allowed patents and 23 patent applications pending worldwide.
The company has a strategic collaboration agreement with Stryker Corporation for technology co-development.
Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
| Country | United States |
| IPO Date | Mar 25, 1992 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Harel Gadot |
Contact Details
Address: 25 Recreation Park Drive Hingham, Massachusetts United States | |
| Website | https://www.microbotmedical.com |
Stock Details
| Ticker Symbol | MBOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000883975 |
| CUSIP Number | 59503A204 |
| ISIN Number | US59503A2042 |
| Employer ID | 94-3078125 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Harel Gadot | Co-Founder, President, Chief Executive Officer & Chairman |
| Dr. Juan Diaz-Cartelle | Chief Medical Officer |
| Michal Ahuvia | Director of Operations |
| Paul Mullen | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2025 | 8-K | Current Report |
| Apr 29, 2025 | DEF 14A | Filing |
| Apr 29, 2025 | ARS | Filing |
| Apr 29, 2025 | DEFA14A | Filing |
| Apr 23, 2025 | 8-K | Current Report |
| Apr 17, 2025 | PRE 14A | Filing |
| Apr 17, 2025 | 8-K | Current Report |
| Apr 15, 2025 | 8-K | Current Report |
| Apr 09, 2025 | 8-K | Current Report |
| Apr 08, 2025 | 424B3 | Filing |